Medrol

Methylprednisolone, the active ingredient in Medrol, is a glucocorticoid presented as an oral tablet for systemic use. It is employed to reduce inflammation and modify immune responses in a range of acute and chronic conditions.\n\nGNH India supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylprednisolone acts on inflammatory and immune pathways to manage several disorders.\n\n- Asthma exacerbations: reduces airway inflammation and improves breathing.\n- Rheumatoid arthritis: decreases joint swelling and pain.\n- Systemic lupus erythematosus: moderates systemic inflammation and organ involvement.\n- Severe allergic reactions: suppresses acute hypersensitivity symptoms.\n- Multiple sclerosis relapses: limits neurologic inflammation and accelerates recovery.

Methylprednisolone may cause a range of adverse reactions, varying by dose and duration.\n\nCommon Side Effects:\n- Increased appetite: may lead to weight gain.\n- Mood changes: irritability or euphoria.\n- Insomnia: difficulty sleeping.\n- Elevated blood glucose: especially in diabetic patients.\n- Gastrointestinal discomfort: nausea or dyspepsia.\n\nSerious or Rare Side Effects:\n- Adrenal suppression: risk of adrenal crisis on abrupt withdrawal.\n- Severe infection: heightened susceptibility to bacterial, viral, or fungal infections.\n- Osteoporosis: bone density loss with long‑term use.\n- Peptic ulcer disease: gastrointestinal bleeding risk.\n- Psychiatric disorders: psychosis or severe depression.

Before initiating therapy, consider patient‑specific factors and monitor for complications.\n\n- Assess infection risk: avoid use in active uncontrolled infections.\n- Screen for diabetes: monitor blood glucose levels regularly.\n- Evaluate bone health: consider calcium and vitamin D supplementation for long‑term therapy.\n- Monitor blood pressure: glucocorticoids can cause hypertension.\n- Review psychiatric history: watch for mood or behavioral changes.\n- Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Methylprednisolone can alter the activity of several concomitant medicines.\n\nMajor Interactions (Avoid):\n- CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase systemic exposure and toxicity.\n- Live vaccines: risk of attenuated infection due to immunosuppression.\n\nModerate Interactions (Monitor Closely):\n- Anticoagulants (e.g., warfarin): glucocorticoids may enhance anticoagulant effect, requiring INR monitoring.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): combined use raises gastrointestinal ulcer risk.\n- Diabetic agents: may require dose adjustment as steroids raise glucose levels.